Company Overview of Chiesi USA, Inc.
Chiesi USA, Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of prescription pharmaceutical drugs for the hospital and adjacent specialty markets. The company offers CARDENE I.V., a premixed injection for the short-term treatment of hypertension; CUROSURF, a natural lung surfactant for the treatment of respiratory distress syndrome in premature infants; and ZYFLO, a leukotriene synthesis inhibitor for prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. It also provides BETHKIS, an inhaled tobramycin-based product for the management of cystic fibrosis patients with pseudomonas aeruginosa; and hyd...
1255 Crescent Green Drive
Cary, NC 27518
Key Executives for Chiesi USA, Inc.
Chairman and Chief Executive Officer
Chief Financial Officer and Vice President of Finance
Principal Accounting Officer and Director of Accounting
Vice President of Clinical and Regulatory
Compensation as of Fiscal Year 2014.
Chiesi USA, Inc. Key Developments
Cornerstone Therapeutics Inc. has Changed its Name to Chiesi USA, Inc
Apr 28 14
On April 28, 2014, Cornerstone Therapeutics Inc. changed its name to Chiesi USA, Inc.
Cornerstone Therapeutics Inc. Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-12-2014
Mar 21 14
Cornerstone Therapeutics Inc. Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-12-2014 . Venue: London, United Kingdom.
Cornerstone Therapeutics Inc.(NasdaqGM:CRTX) dropped from Russell 2000 Index
Feb 16 14
Cornerstone Therapeutics Inc. will be removed from the Russell 2000 Index.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries